Cigna slips and Humana gains on report of renewed merger talks
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Deutsche Bank Reiterates Hold Rating on Humana (HUM)
October 22, 2024 5:37 AM EDTDeutsche Bank analyst George Hill reiterated a Hold rating and $250.00 price target on Humana (NYSE: HUM).
The analyst comments "Maintain Hold on HUM Shares: We maintain our Hold rating on Humana's shares and our target price of $250, which represents 12.5x our 2025 EPS... More
